Loading insider details...
Beta
Latest Form 4 (Sep 24, 2026): Exercise/Conversion of 12,500 AKTS shares, $61.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Aktis Oncology, Inc. (AKTS) | Exercise/Conversion | 12,500 | $61.9K |
| Jul 10, 2026 | Aktis Oncology, Inc. (AKTS) | Exercise/Conversion | 50,000 | $247.5K |